Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ye-Han Liu"'
Autor:
Xu Lin, Ye-han Liu, Huan-qi Zhang, Lin-wen Wu, Qi Li, Jun Deng, Qingyi Zhang, Yuhong Yang, Chong Zhang, Yang-ling Li, Jian Hu
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Lung cancer is a leading cause of cancer-related deaths, and the most common type is lung adenocarcinoma (LUAD). LUAD is frequently diagnosed in people who never smoked, patients are always diagnosed at advanced inoperable stages, and the pr
Externí odkaz:
https://doaj.org/article/dba53029d6364141863fbe0bb3e9d577
Autor:
Yang-ling Li, Man-man Zhang, Lin-wen Wu, Ye-han Liu, Zuo-yan Zhang, Ling-hui Zeng, Neng-ming Lin, Chong Zhang
Publikováno v:
Journal of Biomedical Science, Vol 29, Iss 1, Pp 1-19 (2022)
Abstract Background Hepatocellular carcinoma (HCC) accounts for the majority of liver cancer cases, while metastasis is considered the leading cause of HCC-related death. However, the currently available treatment strategies for efficient suppression
Externí odkaz:
https://doaj.org/article/3e90ba0444124405bd834aefc6813435
Glioma is one of the most primary malignant brain tumors, and glioblastoma multiform (GBM) is the most common and highly aggressive glioma. Most GBM are high malignant, poor prognosis, resistant to conventional therapy, and prone to recurrence. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9edd281ea6553842054aef7a897d763f
https://doi.org/10.21203/rs.3.rs-2473762/v1
https://doi.org/10.21203/rs.3.rs-2473762/v1
Autor:
Jiaan Shao, Shu-Min Dong, Ye-Han Liu, Huajian Zhu, Hua-Qing Liu, Linghui Zeng, Yang-ling Li, Chong Zhang, Man-Man Zhang, Jiankang Zhang, Zuo-Yan Zhang
Publikováno v:
Anti-Cancer Drugs.
Vinpocetine is widely used to treat cerebrovascular diseases. However, the effect of vinpocetine to treat hepatocellular carcinoma (HCC) has not been investigated. In this study, we revealed that vinpocetine was associated with antiproliferative acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6039f0ed290e099cd82dac2ef003a6f
https://doi.org/10.1097/cad.0000000000001056
https://doi.org/10.1097/cad.0000000000001056
Autor:
Zuo-yan Zhang, Shu-min Dong, Ye-han Liu, Man-man Zhang, Jian-kang Zhang, Hua-jian Zhu, Jia-an Shao, Hua-qing Liu, Yang-ling Li, Chong Zhang, Ling-hui Zeng
Publikováno v:
Anti-Cancer Drugs; Aug2021, Vol. 32 Issue 7, p727-733, 7p